Related references
Note: Only part of the references are listed.Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis
Mohammed Suhail Akhter et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2010)
Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease
Ahmet Var et al.
MOLECULAR BIOLOGY REPORTS (2009)
Factor VHR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden
Zaher K. Otrock et al.
ANNALS OF HEMATOLOGY (2008)
Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients
Aydan Eroglu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2007)
Thrombophilia and risk of venous thrombosis in patients with cancer
Herve Decousus et al.
THROMBOSIS RESEARCH (2007)
Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients
M Kennedy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Virchow's triad revisited: The importance of soluble coagulation factors, the endothelium, and platelets
AD Blann et al.
THROMBOSIS RESEARCH (2001)
Update on tumor cell procoagulant factors
AJ Gale et al.
ACTA HAEMATOLOGICA (2001)
Pathogenetic mechanisms of thrombosis in malignancy
MB Donati et al.
ACTA HAEMATOLOGICA (2001)
Share Paper
